UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) February 9, 2010
Continucare Corporation
(Exact Name of Registrant as Specified in Charter)
Florida
(State or Other Jurisdiction of Incorporation)
| |
|
|
| 1-12115
|
|
59-2716023 |
| (Commission File Number)
|
|
(IRS Employer Identification No.) |
| |
|
|
| 7200 Corporate Center Drive, Suite 600 |
|
|
| Miami, Florida
|
|
33126 |
| (Address of Principal Executive Offices)
|
|
(Zip Code) |
(305) 500-2000
(Registrant’s telephone number, Including Area Code)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425) |
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
|
|
|
| Item 5.02. |
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers. |
On February 9, 2010, the shareholders of Continucare Corporation (the “Company”) approved an
amendment of the Company’s Amended and Restated 2000 Stock Incentive Plan (the “Amendment”) at the
Company’s 2010 Annual Meeting of Shareholders. The purpose of the Amendment was to increase the
aggregate number of shares of common stock authorized for issuance under the plan from 9,000,000 to
13,000,000 and to extend the expiration date of the plan from 2010 to 2020. The foregoing summary
description of the Amendment is qualified in its entirety by reference to the actual terms of the
Amended and Restated 2000 Stock Incentive Plan, which is included as Exhibit 10.1 to this Current
Report on Form 8-K and incorporated herein by reference.
Dr. Luis Cruz was not nominated as a director for re-election at the Company’s 2010 Annual Meeting
of Shareholders. As a result, effective February 9, 2010, Dr. Cruz was no longer a member of the
Board of Directors of the Company. Dr. Marvin A. Sackner was nominated to replace Dr. Cruz as a
member of the Board of Directors of the Company.
Item 8.01. Other Events.
On February 9, 2010, the Company held its 2010 Annual Meeting of Shareholders. Below is a summary
of the proposals and corresponding votes.
All eight nominees were elected with each director receiving votes as follows:
| |
|
|
|
|
| Nominee
|
|
For
|
|
Withheld |
|
|
|
|
|
|
| Richard C. Pfenniger, Jr.
|
|
42,271,543
|
|
1,322,145 |
| Robert J. Cresci,
|
|
43,088,630
|
|
505,058 |
| Neil Flanzraich,
|
|
42,862,187
|
|
731,501 |
| Phillip Frost, M.D.
|
|
34,394,398
|
|
9,199,290 |
| Jacob Nudel, M.D.
|
|
43,085,483
|
|
508,205 |
| Marvin A. Sackner, M.D.
|
|
43,072,783
|
|
520,905 |
| Jacqueline M. Simkin
|
|
43,085,051
|
|
508,637 |
| A. Marvin Strait
|
|
43,080,588
|
|
513,100 |
There were 12,591,437 broker non-votes on this proposal.
The Amendment, as described above, was approved by the Company’s shareholders as follows:
| |
|
|
|
|
| For
|
|
Against
|
|
Abstain |
|
|
|
|
|
|
| 34,560,685
|
|
8,940,247
|
|
92,756 |
There were 12,591,437 broker non-votes on this proposal.
The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered
public accounting firm:
| |
|
|
|
|
| For
|
|
Against
|
|
Abstain |
|
|
|
|
|
|
| 55,757,694
|
|
245,515
|
|
181,916 |
2